Content continues after advertisement

One-Year Conditional Survival of Dogs & Cats with Mammary Carcinomas

Haley J. Leeper, DVM, DACVIM (Oncology), Oregon State University

Oncology

|January/February 2022

Sign in to Print/View PDF

In the Literature

Chocteau F, Mordelet V, Dagher E, Loussouarn D, Abadie J, Nguyen F. One-year conditional survival of dogs and cats with invasive mammary carcinomas: a concept inspired from human breast cancer. Vet Comp Oncol. 2021;19(1):140-151.


FROM THE PAGE …

Canine and feline mammary carcinomas exhibit a wide range of clinical behaviors, depending on numerous histologic and clinical factors.1-7 Veterinary oncologists typically use median survival time after cancer is diagnosed to predict survival rates. Conditional survival, frequently used in human oncology, is the probability of continued survival (measured in months) based on how many months the patient has already survived since the time of diagnosis. This can be further refined based on whether certain criteria are met.

This study sought to describe the one-year overall and cancer-specific conditional survival of female dogs and cats with invasive mammary carcinomas. A secondary goal was to analyze the influence of epidemiologic, clinical, histopathologic, and immunohistochemical parameters on conditional survival.

Records of 344 dogs and 342 cats were retrospectively reviewed for patients with invasive mammary carcinomas treated with surgery alone and with a 2-year follow-up. Dogs that lived at least one year after diagnosis were relatively protected against cancer-related death. The one-year conditional specific survival probability increased from 59% to 80% in this population of dogs. Factors associated with conditional survival in dogs included patient age, nodal stage, cancer stage, lymphovascular invasion, proliferation index, and margin status. 

Feline mammary carcinoma remains a life-threatening condition, even when survival is one year after diagnosis; one-year conditional specific survival probability increased from 48% to 52% in cats.

Conditional survival has been used for a variety of tumors in human medicine, including breast and pancreatic cancer, but has not been investigated in veterinary oncology. Conditional survival is potentially useful for more accurately estimating patient outcomes, especially when identifying prognostic factors in those patients surviving the period in which they are most likely to succumb to disease.


… TO YOUR PATIENTS

Key pearls to put into practice:

1

Some dogs diagnosed with mammary carcinomas treated with surgery alone may be relatively protected from cancer-related death if they live at least one year following diagnosis, but this does not appear to be the case for cats.

2

The most significant factors associated with increased conditional survival in dogs include patient age, nodal stage, cancer stage, margin status, and lymphovascular invasion.

 

3

Surgical dose and adjuvant chemotherapy were not evaluated in this study but have been important in managing canine and feline mammary carcinomas.

References

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy